MPM BioImpact reported a 4.1% stake in Compass Therapeutics CMPX · 5,622,505 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 4.1%
Last report: 6.2% · filed 25/02/14
Shares held: 5,622,505 sh
Class: Common Stock, par value $0.001 per share
Stock: Compass Therapeutics CMPX
Holder: MPM BioImpact
Event date: 25/06/30
Filed: 25/08/12

4.1% stake · below 5%

Stake: 4.1%
Last report: 6.2%
Since last report: −2.1pp

Compass Therapeutics trades, last 26 weeks

What else happened in Compass Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

MPM BioImpact's other 5% stake reports

MPM BioImpact
5% stakeContext Therapeutics
5% stake
Context Therapeutics
CNTX
1.4% stake
1,299,046 sh
1.4% stake
Filed 08/14
MPM BioImpact
5% stakeDBV Technologies
5% stake
DBV Technologies
DBVT
6.2% stake
18,331,420 sh
6.2% stake
Filed 08/14
MPM BioImpact
5% stakeClimb Bio
5% stake
Climb Bio
CLYM
0% stake
0 sh
0% stake
Filed 08/14
MPM BioImpact
5% stakeDBV Technologies
5% stake
DBV Technologies
DBVT
8.8% stake
26,066,806 sh
8.8% stake
Filed 05/15
MPM BioImpact
5% stakeDBV Technologies
5% stake
DBV Technologies
DBVT
9.9% stake
24,579,307 sh
9.9% stake
Filed 02/17